| Not Yet Recruiting | Clinical Feasibility of the ARCHITECT Applicator in Cervical Cancer Brachytherapy NCT07435987 | Erasmus Medical Center | N/A |
| Not Yet Recruiting | Cadonilimab Combined With RT in LACC Patients Ineligible for CCRT NCT07450963 | Ruijin Hospital | Phase 2 |
| Recruiting | A Clinical Study of Nanocrystalline Megestrol Acetate in Concurrent Chemoradiotherapy for Locally Advanced Cer NCT07338487 | Second Xiangya Hospital of Central South University | Phase 1 |
| Not Yet Recruiting | This is a Multicentre International Study Evaluating CT-based IGABT With / Without Either TRUS During BT/Pre B NCT07249021 | Homi Bhabha Cancer Hospital & Research Centre | — |
| Recruiting | Neoadjuvant Iparomlimab and Tuvonralimab Plus Chemotherapy-eclipse for Locally Advanced Cervical Cancer (NICE- NCT07055399 | Fujian Cancer Hospital | Phase 2 |
| Not Yet Recruiting | Neoadjuvant Chemo-immunotherapy Followed by Concurrent Chemoradiotherapy and Immunotherapy in LACC NCT06916117 | RenJi Hospital | Phase 2 |
| Active Not Recruiting | A Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (IVOLGA) NCT06943833 | AstraZeneca | Phase 2 |
| Active Not Recruiting | QL1706 Plus Neoadjuvant Chemotherapy Followed by Type I Hysterectomy for Locally Advanced Cervical Cancer NCT07205497 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Phase 2 |
| Completed | US Radiomics in Advanced Cervical Cancer NCT06984289 | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | — |
| Not Yet Recruiting | A Clinical Study of Pelvic Concurrent Chemoradiotherapy Combined with CT-guided Intracavitary Brachytherapy wi NCT06882473 | Peking University Third Hospital | N/A |
| Recruiting | Neoadjuvant Chemotherapy Plus Cadonilimab for Locally Advanced Cervical Cancer NCT07104149 | The First Affiliated Hospital of Zhengzhou University | Phase 2 |
| Not Yet Recruiting | Study of Laparoscopic Radical Hysterectomy Based on Space Anatomy in Patients With IB3 and IIA2 Cervical Cance NCT06759480 | International Peace Maternity and Child Health Hospital | — |
| Recruiting | Study on Disease Characteristics and Treatment in Locally Advanced or Recurrent / Metastatic Cervical Cancer i NCT06771193 | MSD Italia S.r.l. | — |
| Enrolling By Invitation | CNCMT：a Multi-center, Prospective, Single-arm Study NCT06714084 | Hubei Cancer Hospital | N/A |
| Recruiting | Neoadjuvant Immunochemotherapy in PD-L1-negative LACC NCT06288360 | Tongji Hospital | Phase 2 |
| Recruiting | Neoadjuvant Chemoimmunotherapy Versus Concurrent Chemoradiotherapy for LACC NCT06288373 | Tongji Hospital | Phase 2 / Phase 3 |
| Active Not Recruiting | A Study of Chemoradiotherapy With SHR-1316 For Treatment of Locally Advanced Cervical Cancer NCT06237257 | Shanghai Shengdi Pharmaceutical Co., Ltd | Phase 2 |
| Recruiting | MicroEnvironment Tumor Effects of Radiotherapy - Comprehensive Radiobiology Assessment TRial NCT05975593 | Washington University School of Medicine | N/A |
| Recruiting | Zimberelimab Combined With Albumin-bound Paclitaxel and Cisplatin in Neoadjuvant Treatment of LACC NCT06055738 | Tang-Du Hospital | Phase 2 |
| Recruiting | Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical) NCT06079671 | AstraZeneca | Phase 3 |
| Not Yet Recruiting | Study of Chemoradiotherapy With Envafolimab For The Treatment of Locally Advanced Cervical Cancer NCT05799469 | Chongqing University Cancer Hospital | Phase 2 |
| Recruiting | Curcumin Supplementation in Cervical Cancer NCT06080841 | National Institute of Cancerología | N/A |
| Unknown | A Prospective Study on the Prediction Model of Para-aortic Lymph Node Metastasis NCT06068387 | Chongqing University Cancer Hospital | N/A |
| Recruiting | Study Of Cadonilimab Combined With Radiotherapy In The Treatment of Locally Advanced Cervical Cancer NCT05687851 | Chongqing University Cancer Hospital | Phase 2 |
| Recruiting | Study on the Relationship Between Plasma MRD and cfDNA HPV and the Efficacy and Prognosis of Locally Advanced NCT05950087 | Guizhou Provincial People's Hospital | — |
| Unknown | Assessment of Prognosis Using Peripheral Blood Circulating Tumor DNA in Patients With Cervical Cancer NCT05602831 | Fudan University | — |
| Unknown | Zimberelimab Combined With Concurrent Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer NCT05437692 | Shanghai Zhongshan Hospital | Phase 2 |
| Recruiting | Comparing the Efficacy of Surgery Staging and Image Staging of Locally Advanced Cervical Cancer NCT05378087 | Chongqing University Cancer Hospital | N/A |
| Completed | Predictors of Para-aortic Lymph Node Metastasis of Cervical Cancer NCT05717751 | Chongqing University Cancer Hospital | — |
| Unknown | PD-1 Antibody Plus Chemoradiotherapy for IB2-IIIB Cervical Cancer NCT05311566 | Lei Li | Phase 2 |
| Completed | A Retrospective Analysis: Whether Five Factors Affect PFS in Patients With Locally Advanced Cervical Cancer NCT05779111 | Chongqing University Cancer Hospital | — |
| Withdrawn | MR-Guided High-Intensity Focused Ultrasound in Conjunction With Radiation Therapy for the Treatment of Locally NCT03977311 | Washington University School of Medicine | N/A |
| Unknown | Carboplatin-Paclitaxel-Pembrolizumab in Neoadjuvant Treatment of Locally Advanced Cervical Cancer NCT04238988 | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Phase 2 |
| Unknown | Camrelizumab Combined With Radiotherapy and Chemotherapy for the Treatment of Recurrent or Metastatic Cervical NCT04884906 | Tianjin Medical University Cancer Institute and Hospital | Phase 2 |
| Completed | Rectovaginal Fistula in Post-Radiotherapy Advanced Cervical Cancer Patients NCT05059119 | Far Eastern Memorial Hospital | — |
| Completed | Lymphatic Mapping for Image Guided Radiotherapy in Patients With LACC - a Feasibility Study NCT05746156 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | N/A |
| Recruiting | Evaluation of Concomitant Chemo-radiotherapy With Cisplatine vs Gemcitabin in Locally Advanced Cervicouterine NCT06156514 | National Institute of Cancerología | Phase 3 |
| Unknown | NAC Followed by RH for the Treatment of LACC NCT03963882 | Lei Li | Phase 2 |
| Completed | Study of Durvalumab With Chemoradiotherapy for Women With Locally Advanced Cervical Cancer (CALLA) NCT03830866 | AstraZeneca | Phase 3 |
| Completed | Trial Assessing the Inhibitor of Programmed Cell Death Ligand 1 (PD-L1) Immune Checkpoint Atezolizumab NCT03612791 | Gustave Roussy, Cancer Campus, Grand Paris | Phase 2 |
| Completed | Nivolumab in Association With Radiotherapy and Cisplatin in Locally Advanced Cervical Cancers Followed by Adju NCT03298893 | Institut Curie | Phase 1 / Phase 2 |
| Unknown | Observation and Evaluation of Short-term Curative Effect of Local Advanced Cervical Cancer Treated With Partic NCT03225443 | Shanghai First Maternity and Infant Hospital | — |
| Terminated | Stereotactic Body Radiation Therapy (SABR) for Definitive Treatment of Locally Advanced Cervical Cancer NCT02045433 | University of Texas Southwestern Medical Center | Phase 2 |
| Unknown | Preoperative Chemoradiotherapy Combined With Nimotuzumab for Cervical Cancer NCT01938105 | People's Hospital of Guangxi Zhuang Autonomous Region | Phase 2 |
| Completed | A Study of mTOR Inhibitor Everolimus (RAD001) in Association With Cisplatin and Radiotherapy for Locally Advan NCT01217177 | Novartis Pharmaceuticals | Phase 1 |
| Completed | Dose Escalation Study of Simultaneous Boost Intensity-Modulated Radiotherapy for Locally Advanced Cervical Can NCT01230996 | Barts & The London NHS Trust | Phase 1 / Phase 2 |
| Withdrawn | An Initial Feasibility Study to Integrate MRI Based Brachytherapy and CT/MR Fused INRT in Treatment of Advance NCT01514955 | AHS Cancer Control Alberta | Phase 1 |
| Unknown | Randomized Trial Between Weekly and 5 Day 3 Weekly Cisplatin for Cervical Cancer NCT00548821 | National University Hospital, Singapore | Phase 3 |